EULAR 2019 wraps this weekend in Madrid. In this slideshow, we highlight some of the most noteworthy findings, beginning with a possible new treatment combination for patients who have both gout and kidney disease.
A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings, but we'd like to know what you think. Email us your comments at [email protected].
The American College of Rheumatology and the Arthritis Foundation have updated the 2013 treatment guidelines for juvenile idiopathic arthritis (JIA), which includes juvenile non-systemic polyarthritis, sacroiliitis, and enthesitis. In this slideshow, we highlight the recommendations.
The rheumatology physician shortage is expected to continue to decline through 2030, a report shows. Key recommendations have been made to close the gap in services.
Our Top Stories in Rheumatology: Daily tofacitinib, pregnancy outcomes, pediatric lupus, RA risk and more
In this slideshow, we highlight the news you may have missed: Prescribing information for a newly approved treatment for pediatric lupus, new reports on negative pregnancy outcomes in PsA and ankylosing spondylitis, new information on the benefits of daily tofacitinib, and much more.
From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics.
Glucocorticoids are highly effective in treating inflammatory conditions. However, these medications also pose a significant risk for bone loss and fracture. In this slideshow, we cover the treatment guidelines.
Which biologics do patients like best? Does methotrexate cause intestinal lung disease? A combination treatment that reduces bad cholesterol. These are among the studies we highlight in this week's weekend slideshow.
To help clinicians manage antirheumatic drug therapy, the ACR and the American Association of Hip and Knee Surgeons developed evidence-based guidelines for the perioperative management of antirheumatic medication for patients with rheumatic diseases undergoing knee or hip surgery. In this slideshow, we outline those recommendations.
It may have multi positive uses, but there are risks associated with using aspirin and other NSAIDs. In this slideshow, we highlight some recent findings that address how to calculate NSAID-related cardiovascular risk, a study that shows aspirin reduces cancer risk and another that says if taken appropriately, it can reduce the changes of major adverse cardiovascular events in diabetes patients.